Azadeh Jafari Ashtiani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Azadeh Jafari Ashtiani has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Maliheh Arab
Department of Gyneco-oncology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 shared publications- Ahmadali Davar
Department of Radiology, Shohada‐e‐Tajrish Hospital Shahid Beheshti University of Medical Sciences Tehran Iran
1 shared publication - Ali Pirsalehi
Department of Internal Medicine, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
1 shared publication Behnaz Ghavami
Obstetrics and Gynecology Department, Arash Women’s Hospital, Tehran University of Medical Sciences, Tehran, Iran
1 shared publicationBehnaz Nouri
Department of Obstetrics and Gynecology, Shohada Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
1 shared publication- Elahe Sadati
Department of Obstetrics and Gynecology, Shohada‐e‐Tajrish Hospital Shahid Beheshti University of Medical Sciences Tehran Iran
1 shared publication
Latest Publications
- Open Access
- 31 January 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (2) , e70149
Intussusception and Internal Hernia After Roux‐en‐Y Gastric Bypass Surgery in a Woman With Twin Pregnancy: A Case Report
Severe obesity is a global concern now, and bariatric surgery has been proven to be the best solution. Most candidates are women of reproductive age; therefore, an increasing number of pregnant women with the history of gastric bypass is noticed. A 33‐year‐old woman at 23 weeks' gestation with a twin pregnancy, with a history of bariatric surgery 2 years prior her pregnancy, presented to our hospital with small bowel necrosis due to internal hernia and intussusception, we proceeded to laparotomy and resection of the necrotic segment of the bowel. The patient underwent cesarean section on the 35 weeks of her pregnancy due to preterm labor and intra uterine growth retardation of the fetuses. Since the gravid uterus increases the intraabdominal pressure, the complications of bariatric surgery such as intussusception or internal hernia may occur even more frequently during pregnancy. Although computed tomography scan or ultrasound could assist clinicians for early diagnosis of complications, negative findings could not rule out small bowel obstruction; therefore, in a pregnant woman with persisting abdominal pain, obstipation, and vomiting, exploratory laparotomy or laparoscopy is mandatory. Pregnant women with a history of Roux‐en‐Y gastric bypass surgery (RYGB) should be considered high‐risk obstetric, and symptoms like ongoing abdominal pain, and vomiting should be taken as alarm sign for small bowel obstruction. Computed tomography (CT) scan is the modality of choice for detecting the small bowel obstruction, and is mandatory, taking into consideration the considerable harms to the fetus.
- 31 January 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (2) , e70149
Open AccessIntussusception and Internal Hernia After Roux‐en‐Y Gastric Bypass Surgery in a Woman With Twin Pregnancy: A Case Report
Severe obesity is a global concern now, and bariatric surgery has been proven to be the best solution. Most candidates are women of reproductive age; therefore, an increasing number of pregnant women with the history of gastric bypass is noticed. A 33‐year‐old woman at 23 weeks' gestation with a twin pregnancy, with a history of bariatric surgery 2 years prior her pregnancy, presented to our hospital with small bowel necrosis due to internal hernia and intussusception, we proceeded to laparotomy and resection of the necrotic segment of the bowel. The patient underwent cesarean section on the 35 weeks of her pregnancy due to preterm labor and intra uterine growth retardation of the fetuses. Since the gravid uterus increases the intraabdominal pressure, the complications of bariatric surgery such as intussusception or internal hernia may occur even more frequently during pregnancy. Although computed tomography scan or ultrasound could assist clinicians for early diagnosis of complications, negative findings could not rule out small bowel obstruction; therefore, in a pregnant woman with persisting abdominal pain, obstipation, and vomiting, exploratory laparotomy or laparoscopy is mandatory. Pregnant women with a history of Roux‐en‐Y gastric bypass surgery (RYGB) should be considered high‐risk obstetric, and symptoms like ongoing abdominal pain, and vomiting should be taken as alarm sign for small bowel obstruction. Computed tomography (CT) scan is the modality of choice for detecting the small bowel obstruction, and is mandatory, taking into consideration the considerable harms to the fetus.
- 1 July 2024
- Published by Bentham Science Publishers Ltd. in Current Women s Health Reviews
- Vol. 20 (4) , 1
Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients with Advanced Ovarian Cancer: A 2-year Survival Analysis Study
Background: During the last few years, Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) has entered the national comprehensive cancer network guidelines as a new protocol for improving patients’ outcomes. However, there is no consensus on its long-term efficiency, and it still is under debate. Objectives: This study aims to evaluate the effectiveness of Cytoreductive Surgery Plus hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer in Iran. Method: Thirty patients with Stage IIIc and IV advanced ovarian cancer underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy at Jam Hospital with a fixed surgical team in Tehran, Iran, from 2019 to 2021. Fourteen patients were new cases, and sixteen of them were recurrent cases. At the end of cytoreductive surgery, by using a hyperthermic intraperitoneal chemotherapy device, Cisplatin was circulated in the peritoneal cavity for 90 minutes at a dose of 80-100 mg/ m2 at 43°C. Results: Among 30 patients with 54.97±10.74 years of mean age, the mean overall survival was 564.967 days, and 2-year survival rates were 66.7%. According to Fisher's exact test, there was a statistically significant relationship between disease-free after surgery and mortality rate (p=0.00). However, there was no statistically significant relationship between recurrence after surgery and mortality rate (p=0.093). Conclusion: Based on these findings, cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy had a survival rate of 66.7% within two years in advanced ovarian cancer patients. However, to achieve better results, careful selection of patients and complete cytoreductive surgery should be performed.
- 1 July 2024
- Published by Bentham Science Publishers Ltd. in Current Women s Health Reviews
- Vol. 20 (4) , 1
Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients with Advanced Ovarian Cancer: A 2-year Survival Analysis Study
Background: During the last few years, Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) has entered the national comprehensive cancer network guidelines as a new protocol for improving patients’ outcomes. However, there is no consensus on its long-term efficiency, and it still is under debate. Objectives: This study aims to evaluate the effectiveness of Cytoreductive Surgery Plus hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer in Iran. Method: Thirty patients with Stage IIIc and IV advanced ovarian cancer underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy at Jam Hospital with a fixed surgical team in Tehran, Iran, from 2019 to 2021. Fourteen patients were new cases, and sixteen of them were recurrent cases. At the end of cytoreductive surgery, by using a hyperthermic intraperitoneal chemotherapy device, Cisplatin was circulated in the peritoneal cavity for 90 minutes at a dose of 80-100 mg/ m2 at 43°C. Results: Among 30 patients with 54.97±10.74 years of mean age, the mean overall survival was 564.967 days, and 2-year survival rates were 66.7%. According to Fisher's exact test, there was a statistically significant relationship between disease-free after surgery and mortality rate (p=0.00). However, there was no statistically significant relationship between recurrence after surgery and mortality rate (p=0.093). Conclusion: Based on these findings, cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy had a survival rate of 66.7% within two years in advanced ovarian cancer patients. However, to achieve better results, careful selection of patients and complete cytoreductive surgery should be performed.
- Open Access
- 26 June 2024
- Published by Knowledge E DMCC in Journal of Family & Reproductive Health
- Vol. 18 (2) , 140-145
Role of Bariatric Surgery in Patients With Endometrial Cancer: A Case Report and Review of Literature
Objective: The standard surgery for endometrial cancer can be deferred in some situations, including morbid obesity, comorbidities, and the patient's desire for fertility. One of the options to improve patients' circumstances is bariatric surgery. Case report: This study presented two patients with stage IA, grade I endometrioid endometrial adenocarcinoma. Both patients had morbid obesity and had comorbidities. In case 1, because of fertility preservation, and in case 2, because of severe comorbidities, hormone therapy was started, followed by bariatric surgery after counseling patients. Both patients had acceptable changes in body mass index during follow-up, so cancer surgery through laparoscopy was done. Both patients did not need adjuvant therapy; months after cancer surgery, there is no recurrence, and their body mass index is also decreasing. Conclusion: Bariatric surgery can improve outcomes in patients with morbid obesity who suffer endometrial cancer.
- 26 June 2024
- Published by Knowledge E DMCC in Journal of Family & Reproductive Health
- Vol. 18 (2) , 140-145
Open AccessRole of Bariatric Surgery in Patients With Endometrial Cancer: A Case Report and Review of Literature
Objective: The standard surgery for endometrial cancer can be deferred in some situations, including morbid obesity, comorbidities, and the patient's desire for fertility. One of the options to improve patients' circumstances is bariatric surgery. Case report: This study presented two patients with stage IA, grade I endometrioid endometrial adenocarcinoma. Both patients had morbid obesity and had comorbidities. In case 1, because of fertility preservation, and in case 2, because of severe comorbidities, hormone therapy was started, followed by bariatric surgery after counseling patients. Both patients had acceptable changes in body mass index during follow-up, so cancer surgery through laparoscopy was done. Both patients did not need adjuvant therapy; months after cancer surgery, there is no recurrence, and their body mass index is also decreasing. Conclusion: Bariatric surgery can improve outcomes in patients with morbid obesity who suffer endometrial cancer.
- Open Access
- 1 January 2023
- Vol. 14 (3) , 526-533
Endometrial cancer in women with abnormal uterine bleeding: Data mining classification methods
Background: Over the last decade, artificial intelligence in medicine has been growing. Since endometrial cancer can be treated with early diagnosis, finding a non-invasive method for screening patients, especially high-risk ones, could have a particular value. Regarding the importance of this issue, we aimed to investigate the risk factors related to endometrial cancer and find a tool to predict it using machine learning. Methods: In this cross-sectional study, 972 patients with abnormal uterine bleeding from January 2016 to January 2021 were studied, and the essential characteristics of each patient, along with the findings of curettage pathology, were analyzed using statistical methods and machine learning algorithms, including artificial neural networks, classification and regression trees, support vector machine, and logistic regression. Results: Out of 972 patients with a mean age of 45.77 +/- 10.70 years, 920 patients had benign pathology, and 52 patients had endometrial cancer. In terms of endometrial cancer prediction, the logistic regression model had the best performance (sensitivity of 100% and 98%, specificity of 98.83% and 98.7%, for trained and test data sets respectively,) followed by the classification and regression trees model. Conclusion: Based on the results, artificial intelligence-based algorithms can be applied as a non-invasive screening method for predicting endometrial cancer.
- 1 January 2023
- Vol. 14 (3) , 526-533
Open AccessEndometrial cancer in women with abnormal uterine bleeding: Data mining classification methods
Background: Over the last decade, artificial intelligence in medicine has been growing. Since endometrial cancer can be treated with early diagnosis, finding a non-invasive method for screening patients, especially high-risk ones, could have a particular value. Regarding the importance of this issue, we aimed to investigate the risk factors related to endometrial cancer and find a tool to predict it using machine learning. Methods: In this cross-sectional study, 972 patients with abnormal uterine bleeding from January 2016 to January 2021 were studied, and the essential characteristics of each patient, along with the findings of curettage pathology, were analyzed using statistical methods and machine learning algorithms, including artificial neural networks, classification and regression trees, support vector machine, and logistic regression. Results: Out of 972 patients with a mean age of 45.77 +/- 10.70 years, 920 patients had benign pathology, and 52 patients had endometrial cancer. In terms of endometrial cancer prediction, the logistic regression model had the best performance (sensitivity of 100% and 98%, specificity of 98.83% and 98.7%, for trained and test data sets respectively,) followed by the classification and regression trees model. Conclusion: Based on the results, artificial intelligence-based algorithms can be applied as a non-invasive screening method for predicting endometrial cancer.